"Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer." by Julie N. Graff

Selected Works of Carlo B. Bifulco, M.D.

Follow Contact

Article

Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer.

Cancer immunology research (2014)

Julie N. Graff, Oregon Health & Science University
Sachin Puri, Providence Portland Medical Center
Carlo B. Bifulco, Pathology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center
Bernard A. Fox, Robert W. Franz Cancer Research Center, Earle A Chiles Research Institute
Tomasz M. Beer, Oregon Health & Science University

Link

Disciplines

Immunology and Infectious Disease,
Medicine and Health Sciences and
Oncology

Publication Date

May 1, 2014

DOI

10.1158/2326-6066.CIR-13-0193

Citation Information

Julie N. Graff, Sachin Puri, Carlo B. Bifulco, Bernard A. Fox, et al.. "Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer." Cancer immunology research Vol. 2 Iss. 5 (2014) p. 399 - 403
Available at: http://works.bepress.com/carlo-bifulco/115/